Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 7
Posts 987
Boards Moderated 1
Alias Born 02/13/10
160x600 placeholder
Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers "Business Wire" - 9/18/2014 4:07:00 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 9/16/2014 12:31:06 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 9/12/2014 4:11:24 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/10/2014 10:16:54 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/4/2014 5:54:05 PM
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China "Business Wire" - 9/4/2014 7:30:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/22/2014 7:06:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2014 4:07:13 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2014 3:54:17 PM
Navidea Announces Second Quarter 2014 Financial Results; Total Revenues Grow to $1.1 Million "Business Wire" - 8/6/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Second Quarter 2014 Financial Results on August 6, 2014 "Business Wire" - 7/29/2014 9:37:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2014 5:18:04 PM
Navidea Biopharmaceuticals Announces 2014 Annual Meeting Results "Business Wire" - 7/17/2014 3:44:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/16/2014 4:08:06 PM
Navidea Joins Essex Woodland’s Rheumco to Develop Radiopharmaceuticals for Detection and Treatment of Arthritic Diseases "Business Wire" - 7/16/2014 7:30:00 AM
Navidea Biopharmaceuticals to Present at the 9th Annual JMP Securities Healthcare Conference "Business Wire" - 6/17/2014 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2014 3:51:13 PM
U.S. FDA Approves Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection for Expanded Use in He... "Business Wire" - 6/13/2014 12:26:00 PM
Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation i... "Business Wire" - 6/11/2014 7:30:00 AM
Navidea Biopharmaceuticals Announces Positive Lymphoseek® (technetium Tc 99m tilmanocept) Injection Results on Injection Tim... "Business Wire" - 6/10/2014 4:30:00 PM
Navidea Announces Data Demonstrating Potential of Manocept™ Platform to Diagnose Rheumatoid Arthritis and Kaposi’s Sarcoma "Business Wire" - 6/10/2014 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/6/2014 10:38:45 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/6/2014 10:35:40 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/3/2014 2:18:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/2/2014 5:23:46 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist